User profiles for Dave L Dixon
Dave L. DixonProfessor and Chair, Virginia Commonwealth University School of Pharmacy Verified email at vcu.edu Cited by 4734 |
[HTML][HTML] Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe disease …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe disease …
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association …
…, V Bittner, LPC Brewer, SH Demeter, DL Dixon… - Journal of the American …, 2023 - jacc.org
Aim The “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients
With Chronic Coronary Disease” provides an update to and consolidates new evidence …
With Chronic Coronary Disease” provides an update to and consolidates new evidence …
The cardiometabolic health alliance: working toward a new care model for the metabolic syndrome
…, KK Collins, S Cook, NV Dhurandhar, DL Dixon… - Journal of the American …, 2015 - jacc.org
The Cardiometabolic Think Tank was convened on June 20, 2014, in Washington, DC, as a
“call to action” activity focused on defining new patient care models and approaches to …
“call to action” activity focused on defining new patient care models and approaches to …
2023 ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction: a report of the American College of Cardiology …
…, K Amancherla, LL Davis, A Deswal, DL Dixon… - Journal of the American …, 2023 - jacc.org
The American College of Cardiology (ACC) has a long history of developing documents (eg,
decision pathways, health policy statements, appropriate use criteria) to provide members …
decision pathways, health policy statements, appropriate use criteria) to provide members …
Collaborative drug therapy management and comprehensive medication management―2015
…, S Benavides, EA Chester, DL Dixon… - … : The Journal of …, 2015 - Wiley Online Library
The American College of Clinical Pharmacy ( ACCP ) previously published position statements
on collaborative drug therapy management ( CDTM ) in 1997 and 2003. Since 2003, …
on collaborative drug therapy management ( CDTM ) in 1997 and 2003. Since 2003, …
Effects of sodium‐glucose cotransporter 2 inhibitors on 24‐hour ambulatory blood pressure: a systematic review and meta‐analysis
Background Sodium‐glucose cotransporter 2 (SGLT2) inhibitors are a novel class of
antihyperglycemic agents that improve glycemic control by increasing glycosuria. Additional …
antihyperglycemic agents that improve glycemic control by increasing glycosuria. Additional …
Interleukin‐1 blockade inhibits the acute inflammatory response in patients with ST‐segment–elevation myocardial infarction
…, MG Del Buono, A Schatz, C Vo, DL Dixon… - Journal of the …, 2020 - Am Heart Assoc
Background ST ‐segment–elevation myocardial infarction is associated with an intense acute
inflammatory response and risk of heart failure. We tested whether interleukin‐1 blockade …
inflammatory response and risk of heart failure. We tested whether interleukin‐1 blockade …
Select Drug-Drug Interactions With Direct Oral Anticoagulants: JACC Review Topic of the Week
Millions of individuals in the United States require long-term treatment with an oral anticoagulant.
For decades, vitamin K antagonists were the only oral option available; however, they …
For decades, vitamin K antagonists were the only oral option available; however, they …
Systolic blood pressure time in target range and cardiovascular outcomes in patients with hypertension
Background Standard blood pressure control metrics may not account for fluctuations in blood
pressure over time. Objectives This study sought to estimate the independent association …
pressure over time. Objectives This study sought to estimate the independent association …
Intensive versus standard blood pressure control in SPRINT-eligible participants of ACCORD-BP
OBJECTIVE We sought to determine the effect of intensive blood pressure (BP) control on
cardiovascular outcomes in participants with type 2 diabetes mellitus (T2DM) and additional …
cardiovascular outcomes in participants with type 2 diabetes mellitus (T2DM) and additional …